NCT Number: NCT01820975
Manipulation of Dietary Protein and the Anabolic Response
In the present study, the effect of habitual dietary protein on the anabolic response will be investigated.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–35 year
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Males
- Aged between 18-35 years
- Healthy, recreationally active
- BMI < 30 kg/m2
Exclusion criteria
- Smoking
- Allergies to milk proteins (whey or casein)
- Vegetarians
- Diagnosed GI tract diseases
- Female
- Arthritic conditions
- A history of neuromuscular problems
- Previous participation in amino acid tracer studies
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications
Treatment and study plan
Placebo Comparator
OtherNo protein intake
Other names: control group
Primary outcomes
-
Muscle protein fractional synthetic rate following protein ingestion
Time frame: 3 hours
The ability of the muscle to synthesise new proteins will be assessed over a 3 h period following protein ingestion and will be compared between groups. This only occurs on one occasion.
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Maastricht University Medical Center
Other
Registry information
Official study title
The Manipulation of Dietary Protein Intake on the Anabolic Response in Healthy Young Men
Acronym: PRO-ADAPT
Important dates
- Study start
- 2013
- Primary completion
- 2015
- Study completion
- 2017
- First posted
- Mar 29, 2013
- Registry last updated
- Mar 22, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
LIver FRAilty Management IN Cirrhosis (LIFRAMIN)
NCT06573229
Atrophy, Cirrhosis, Liver
Rome, Italy
View Trial DetailsAl Prediction of Sarcopenia Risk in Neurocritical ICU Patients
NCT07712198
Atrophy, Brain Diseases
Trabzon, Turkey (Türkiye)
View Trial DetailsTai Chi Exercise to Improve Quality of Life and Depression in Elderly With Sarcopenia
NCT07831356
Atrophy, Behavior
Makassar, South Sulawesi, Indonesia
View Trial DetailsEffect of Combined Exercise Training in Patients With Multiple Sclerosis
NCT06595394
Atrophy, Autoimmune Diseases
Istanbul, Turkey (Türkiye)
View Trial Details